Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Phase III study of tucatinib or placebo in combination with trastuzumab and pertuzumab as maintenance therapy for HER2+metastatic breast cancer (HER2CLIMB-05, trial in progress) | ANNALS OF ONCOLOGY |